See more : ALX Oncology Holdings Inc. (ALXO) Income Statement Analysis – Financial Results
Complete financial analysis of Glenfarne Merger Corp. (GGMCW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Glenfarne Merger Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- OFS Credit Company, Inc. (OCCIO) Income Statement Analysis – Financial Results
- TS Corporation (001795.KS) Income Statement Analysis – Financial Results
- The Alkaline Water Company Inc. (WTER.CN) Income Statement Analysis – Financial Results
- AXYZ Co., Ltd. (1381.T) Income Statement Analysis – Financial Results
- Allegion plc (ALLE) Income Statement Analysis – Financial Results
Glenfarne Merger Corp. (GGMCW)
Industry: Shell Companies
Sector: Financial Services
About Glenfarne Merger Corp.
Glenfarne Merger Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Metric | 2021 |
---|---|
Revenue | 0.00 |
Cost of Revenue | 0.00 |
Gross Profit | 0.00 |
Gross Profit Ratio | 0.00% |
Research & Development | 0.00 |
General & Administrative | 907.48K |
Selling & Marketing | 0.00 |
SG&A | 907.48K |
Other Expenses | 0.00 |
Operating Expenses | 907.48K |
Cost & Expenses | 907.48K |
Interest Income | 0.00 |
Interest Expense | -7.43M |
Depreciation & Amortization | 7.43M |
EBITDA | 6.22M |
EBITDA Ratio | 0.00% |
Operating Income | -1.21M |
Operating Income Ratio | 0.00% |
Total Other Income/Expenses | 7.43M |
Income Before Tax | 6.22M |
Income Before Tax Ratio | 0.00% |
Income Tax Expense | -7.43M |
Net Income | 13.64M |
Net Income Ratio | 0.00% |
EPS | 0.39 |
EPS Diluted | 0.39 |
Weighted Avg Shares Out | 34.92M |
Weighted Avg Shares Out (Dil) | 34.92M |
Source: https://incomestatements.info
Category: Stock Reports